Evidence map›Paper›PMID 19320499›Full record

ArticleBiochemistry2009

Transient opening of fibronectin type III (FNIII) domains: the interaction of the third FNIII domain of FN with anastellin.

Tomoo Ohashi, Anne Marie Augustus, Harold P Erickson

Open access · greenAbstract read
In one paragraph

Article in Biochemistry, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Assembly of fibronectin extracellular matrix.Annual review of cell and developmental biology · 2010
    Review
  12. Cryptic activity within the Type IIICurrent topics in peptide & protein research
    Article
  13. Dynamic structure of plasma fibronectin.Critical reviews in biochemistry and molecular biology
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Tomoo OhashiDepartment of Cell Biology, Duke University Medical Center, Durham, North Carolina 27710, USA. t.ohashi@cellbio.duke.edu
Anne Marie Augustus
Harold P Erickson
Duke University Hospital · USDuke Medical Center · US

Funding

EXTRACELLULAR MATRIX AND CELL ATTACHMENT PROTEINSR01CA047056 · NCI · DUKE UNIVERSITY · PI ERICKSON, HAROLD P · 1988 to 2016
$4.7M
EXTRACELLULAR MATRIX AND CELL ATTACHMENT PROTEINSR37CA047056 · NCI · DUKE UNIVERSITY · PI ERICKSON, HAROLD P · 1993 to 2000
$308k
NCI NIH HHS CA047056NCI NIH HHS R01 CA047056NCI NIH HHS R37 CA047056
6 · The paper itself

Abstract

We previously reported that the fibronectin (FN) type III domains of FN may unfold to interact with anastellin and form FN aggregates. In the present study, we have focused on the interaction between anastellin and the third FN type III domain (III3), which is a key anastellin binding site on FN. Anastellin binding to III3 was monitored by 8-anilino-1-naphthalene sulfonate (ANS) fluorescence. ANS binding to anastellin dramatically increased its emission intensity, but this was reduced to half by the addition of III3, suggesting that ANS and III3 share a common hydrophobic binding site on anastellin. An engineered mutant of III3 that was stabilized by an intrachain disulfide bond did not interact with anastellin, as seen by its failure to interfere with ANS binding to anastellin. We also mutated hydrophobic core residues to destabilize III3 and found that these mutants were still capable of interacting with anastellin. Anastellin binding to III3 was also monitored using an intramolecular green fluorescent protein (GFP)-based fluorescence resonance energy transfer (FRET) construct, in which III3 was flanked by two GFP variants (III3-FRET). Anastellin bound to III3-FRET and caused an increase in the FRET signal. The dissociation constant was estimated to be approximately 210 nM. The binding kinetics of anastellin to III3-FRET fit a first-order reaction with a half-time of approximately 30 s; the kinetics with destabilized III3 mutants were even faster. Matrix-assisted laser desorption ionization-time-of-flight (MALDI-TOF) mass spectrometry suggested that the middle part of III3 became destabilized and protease sensitive upon anastellin binding. Thus, the stability of III3 seems to be a key factor in anastellin binding.

Indexed as

Anilino NaphthalenesulfonatesBinding SitesFibronectinsFluorescence Resonance Energy TransferFluorescent DyesGreen Fluorescent ProteinsKineticsModels, MolecularMutationPeptide FragmentsProtein BindingProtein FoldingProtein Structure, TertiarySpectrometry, FluorescenceSpectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization8-anilino-1-naphthalenesulfonic acidanastellinAnilino NaphthalenesulfonatesFibronectinsFluorescent DyesGreen Fluorescent ProteinsPeptide Fragments

Identifiers

PMID19320499
PMCPMC2680933
OpenAlexW2073466675

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.